In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Alignment Healthcare Inc (NASDAQ: ALHC) closed the day trading at $14.78 down -2.89% from the previous closing price of $15.22. In other words, the price has decreased by -$2.89 from its previous closing price. On the day, 2.73 million shares were traded. ALHC stock price reached its highest trading level at $15.69 during the session, while it also had its lowest trading level at $14.58.
Ratios:
For a better understanding of ALHC, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 3.05 whereas as Long-Term Debt/Eq ratio is at 3.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 ’25 when General Atlantic (ALN HLTH), L sold 17,000,000 shares for $15.28 per share. The transaction valued at 259,760,000 led to the insider holds 44,302,175 shares of the business.
GENERAL ATLANTIC, L.P. sold 17,000,000 shares of ALHC for $259,760,000 on May 19 ’25. The Director now owns 44,302,175 shares after completing the transaction at $15.28 per share. On May 19 ’25, another insider, General Atlantic (ALN HLTH), L, who serves as the Affliliate of the company, bought 17,000,000 shares for $16.24 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2924119552 and an Enterprise Value of 2774947840. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.97 while its Price-to-Book (P/B) ratio in mrq is 27.02. Its current Enterprise Value per Revenue stands at 0.924 whereas that against EBITDA is -81.821.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.22, which has changed by 0.7893462 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $7.05. The 50-Day Moving Average of the stock is -11.42%, while the 200-Day Moving Average is calculated to be 8.31%.
Shares Statistics:
Over the past 3-months, ALHC traded about 3.34M shares per day on average, while over the past 10 days, ALHC traded about 3045510 shares per day. A total of 197.67M shares are outstanding, with a floating share count of 130.88M. Insiders hold about 33.85% of the company’s shares, while institutions hold 59.24% stake in the company. Shares short for ALHC as of 1747267200 were 8888253 with a Short Ratio of 2.66, compared to 1744675200 on 10482265. Therefore, it implies a Short% of Shares Outstanding of 8888253 and a Short% of Float of 6.92.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
